Reschini E, Ferrari C, Peracchi M, Fadini R, Meschia M, Crosignani P G
Clin Endocrinol (Oxf). 1980 Dec;13(6):519-23. doi: 10.1111/j.1365-2265.1980.tb03419.x.
The serum prolactin response to intravenous dopamine infusion (5 micrograms . kg-1 . min-1) was measured in twenty-one healthy subjects, in seven hyperprolactinaemic patients without evidence of a pituitary tumour, and in twenty-one patients with prolactinomas. Mean serum prolactin values were significantly suppressed in all three groups, without any significant difference between the degree of suppression. A decrease of serum prolactin to below 50% of basal values occurred in fifteen healthy subjects, in four patients without evidence of pituitary tumour, and in fourteen patients with prolactinomas. These findings demonstrate that most human prolactin-secreting pituitary adenomas are normally suppressible by exogenously administered dopamine and that dopamine infusion is not able to distinguish between tumorous and non-tumorous hyperprolactinaemia. Since intravenously infused dopamine is believed to inhibit prolactin secretion by acting at pituitary level, it is suggested that a normal functioning of pituitary dopamine receptors is maintained in most human prolactinomas.
对21名健康受试者、7名无垂体肿瘤证据的高催乳素血症患者以及21名催乳素瘤患者,测量了静脉注射多巴胺(5微克·千克⁻¹·分钟⁻¹)后血清催乳素的反应。所有三组的血清催乳素平均值均被显著抑制,抑制程度之间无任何显著差异。15名健康受试者、4名无垂体肿瘤证据的患者以及14名催乳素瘤患者的血清催乳素降至基础值的50%以下。这些发现表明,大多数人分泌催乳素的垂体腺瘤通常可被外源性给予的多巴胺抑制,且多巴胺输注无法区分肿瘤性和非肿瘤性高催乳素血症。由于静脉输注的多巴胺被认为通过作用于垂体水平来抑制催乳素分泌,因此提示大多数人催乳素瘤中垂体多巴胺受体功能正常。